With the arrival of March, Colorectal Cancer Awareness Month, faculty and staff in the Department of Internal Medicine’s Section of Digestive Diseases are redoubling their efforts to spread the word about the importance of screening.
- March 01, 2023
Joseph K. Lim, MD, professor of medicine; vice chief of hepatology, Section of Digestive Diseases; and director of clinical hepatology, was selected as the next editor-in-chief of Clinical Liver Disease.
- February 21, 2023
Warren is the first person in the world to receive a groundbreaking treatment for this rare, serious genetic condition, Wilson Disease, in which excessive amounts of copper accumulates in the body, particularly in the liver and brain. Wilson Disease can cause liver and neurological damage, as well as psychiatric issues with memory, impulse control, and anger. A strong, long-term relationship between Warren and Professor of Medicine Michael Schilsky, MD, the physician who is investigating this treatment, has been essential to this novel treatment which has the potential to help patients all over the world.
- February 13, 2023
Yale’s Digestive Health Center in North Haven, a new hub offering advanced medical and surgical treatments for gastrointestinal issues, welcomed its first patients on January 31, 2023.
- December 21, 2022
The largest clinical trial in history related to liver cancer screening is launching in 2023, funded by the Department of Veterans Affairs. The project is scheduled to recruit 4,700 veterans with cirrhosis from 47 VA medical centers. Cirrhosis is a major risk factor for liver cancer and affects veterans disproportionally.
- December 14, 2022
A Yale study finds that health providers have been slower to prescribe potentially lifesaving medications for hepatitis C when patients suffer from alcohol use disorder, even though the medications would be of great benefit to them.